Why medical care costs in Japan have increased despite declining prices for pharmaceuticals

Naoki Ikegami

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Analysis of the 1979 to 1993 surveys of national claims data shows that, using deflated prices, most of the increase in outpatient care costs is due to drugs, with increases in gross volume and deflated unit prices making equal contributions. Further analysis of detailed prescriptions data obtained from one-tenth of the total sample for 1991 and 1993 reveals that new drugs and originator drugs tend to be selected more often. The present vicious cycle of high launch prices, followed by subsequent cuts in the fee schedule, has led to adverse consequences for the industry, physicians and patients.

Original languageEnglish
Pages (from-to)97-105
Number of pages9
JournalPharmacoEconomics
Volume14
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 1998 Jan 1

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Why medical care costs in Japan have increased despite declining prices for pharmaceuticals'. Together they form a unique fingerprint.

  • Cite this